Home
Scholarly Works
GFR Decline as an Alternative End Point in...
Journal article

GFR Decline as an Alternative End Point in Clinical Trials to Prevent ESRD: Are We Increasing Treatment Uncertainty for the Sake of Feasibility?

Authors

Sontrop JM; Al-Jaishi AA; Garg AX

Journal

American Journal of Kidney Diseases, Vol. 64, No. 6, pp. 841–844

Publisher

Elsevier

Publication Date

December 1, 2014

DOI

10.1053/j.ajkd.2014.10.002

ISSN

0272-6386

Contact the Experts team